Baxter International Inc. is set to attend a symposium in Vienna, Austria, where they will present their new Hemopatch sealing hemostat, a room-temperature collagen pad designed for hemostasis and sealing in both open and minimally invasive surgical procedures. The event marks a significant milestone in the product's development, shaped by a decade-long collaboration with experts and feedback from surgeons.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.